Bpca pharmacology studies - period of performance: 9/14/18 - 9/13/22

Ended Awarded Last action

Contract number
75N94018F00002
Awardee
Awarding agency
Obligated
$9,772,723

Award facts

Opportunity
  • NIHNICHDOPPTB20182 Solicitation number
Contract value 100% obligated
$9,772,722.74 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost No Fee
Place of performance
Durham, NC 27705, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00010 · Nichd: r & d: bpca pharmacology studies (TO2): non-severable -$12,451
Other Administrative Action P00009 · Bpca pharmacology studies (TO2)- period of performance: 9/14/18 - 3/13/25 $0
Funding Only Action P00008 -$365,375
Other Administrative Action P00007 · Bpca pharmacology studies (TO2)- period of performance: 9/14/18 - 9/13/24 $0
Supplemental Agreement for work within scope P00006 · Best pharmaceuticals for children act pharmacology studies $0
Other Administrative Action P00005 · Bpca pharmacology studies (TO2)- period of performance: 9/14/18 - 7/31/23 $0
Other Administrative Action P00004 $0
Other Administrative Action P00003 · Bpca pharmacology studies (TO2)- period of performance: 9/14/18 - 9/13/22 $0
Other Administrative Action P00002 $0
Other Administrative Action P00001 $1,745,388
Original award $8,405,160
Show all 11

About this award

This federal contract award was issued by the National Institute of Child Health and Human Development (NICHD) to Duke University for the Best Pharmaceuticals for Children Act (BPCA) Pediatric Trials Network (BPCA-PTN) program. The contract, valued at up to $9,772,722.74, supports a comprehensive pediatric drug development program, including establishing expert teams to develop clinical protocols, conduct pre-clinical studies, perform formulation development, and execute Phases 1-3 pediatric clinical trials. The contract has a period of performance from September 14, 2018 to September 13, 2022, with a potential ultimate completion date of March 13, 2025. This is a single-award Indefinite Delivery Vehicle (IDV) contract that was not set aside. Duke University, a prestigious private research institution, is the prime contractor for this award, which is part of the larger BPCA-PTN program.

Quick answers

Who was awarded contract 75N94018F00002?

75N94018F00002 was awarded to Duke University by National Institute of Child Health and Human Development (National Institutes of Health) on September 11, 2018.

How much is contract 75N94018F00002 worth?

The government has obligated $9,772,723 on 75N94018F00002.

Is contract 75N94018F00002 an order under another contract?

Yes. 75N94018F00002 is a delivery order under 75N94018D00003, an indefinite delivery contract.

Was contract 75N94018F00002 competed?

The extent of competition for 75N94018F00002 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award